Published in J Clin Immunol on May 01, 2010
Zika Virus: Medical Countermeasure Development Challenges. PLoS Negl Trop Dis (2016) 1.31
Successful treatment of Guillain-Barre syndrome by Ayurvedic treatment. Anc Sci Life (2016) 1.08
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease. J Neuroinflammation (2012) 0.99
Guillain-Barre syndrome after coronary artery bypass surgery. Interact Cardiovasc Thorac Surg (2012) 0.87
Pioglitazone, PPARγ agonist, attenuates experimental autoimmune neuritis. Inflammation (2012) 0.78
Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barré syndrome in vitro. Inflammation (2013) 0.77
Clinical importance of F-waves as a prognostic factor in Guillain-Barré syndrome in children. Korean J Pediatr (2016) 0.75
Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model. Neuropsychiatr Dis Treat (2016) 0.75
Syringomyelia coexisting with guillain-barre syndrome. Ann Rehabil Med (2013) 0.75
A Case of Acute Motor Axonal Neuropathy Mimicking Brain Death and Review of the Literature. Front Neurol (2016) 0.75
Guillain-Barré syndrome in pregnancy: A conservatively managed case. J Family Med Prim Care (2017) 0.75
Commentary. J Neurosci Rural Pract (2014) 0.75
Peroral endoscopic myotomy for treatment of Guillain-Barre syndrome-associated achalasia: A rare case. World J Gastroenterol (2017) 0.75
Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China. PLoS One (2015) 0.75
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol (2008) 6.06
A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol (2007) 2.73
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain (2008) 2.60
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J Clin Invest (2004) 2.25
Residual fatigue in Guillain-Barre syndrome is related to axonal loss. Neurology (2013) 2.01
The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol (2004) 1.96
Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain (2013) 1.93
Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain (2007) 1.87
Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol (2009) 1.67
Guillain-Barré syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry (2011) 1.62
Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun (2007) 1.60
Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2013) 1.57
Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology (2014) 1.33
Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol (2010) 1.16
Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology (2005) 1.15
Neuralgic amyotrophy and hepatitis E virus infection. Neurology (2014) 1.15
TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol (2010) 1.14
Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J Neurol Sci (2005) 1.06
Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun (2011) 1.06
Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect (2009) 1.05
IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins. J Proteome Res (2014) 0.98
Neuralgic amyotrophy associated with Bartonella henselae infection. J Neurol Neurosurg Psychiatry (2010) 0.95
Modifying the Medical Research Council grading system through Rasch analyses. Brain (2011) 0.94
Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome. Microbes Infect (2005) 0.94
Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol (2004) 0.93
Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh. PLoS One (2009) 0.92
Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis (2013) 0.92
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients. J Neuroimmunol (2004) 0.88
Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome. J Immunol (2006) 0.87
PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome. J Clin Microbiol (2007) 0.87
Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors. Ann Neurol (2003) 0.87
Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One (2012) 0.87
Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients. Ann Neurol (2003) 0.86
Origin of ganglioside complex antibodies in Guillain-Barré syndrome. J Neuroimmunol (2007) 0.85
Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS One (2012) 0.85
Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol (2005) 0.85
Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiol Aging (2009) 0.83
Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α. J Immunol (2013) 0.83
Emerging drugs for Guillain-Barré syndrome. Expert Opin Emerg Drugs (2011) 0.82
Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature. J Neurol (2014) 0.82
Long-term outcome of Guillain-Barré syndrome in children. J Peripher Nerv Syst (2014) 0.82
Detection of antibodies in neuropathy patients by synthetic GM1 mimics. Glycobiology (2011) 0.81
Mortality in Guillain-Barre syndrome. Neurology (2013) 0.81
Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome. J Peripher Nerv Syst (2009) 0.81
Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome. J Neuroimmunol (2007) 0.81
Risk factors associated with Campylobacter jejuni infections in Curaçao, Netherlands Antilles. J Clin Microbiol (2003) 0.80
GM3, GM2 and GM1 mimics designed for biosensing: chemoenzymatic synthesis, target affinities and 900 MHz NMR analysis. Carbohydr Res (2008) 0.80
Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol (2006) 0.79
Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP. J Peripher Nerv Syst (2011) 0.78
STD-NMR used to elucidate the fine binding specificity of pathogenic anti-ganglioside antibodies directly in patient serum. Biochemistry (2009) 0.78
High incidence of Guillain-Barre syndrome in children, Bangladesh. Emerg Infect Dis (2011) 0.78
Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms. J Neuroimmunol (2008) 0.78
Selective digestive tract decontamination decreases time on ventilator in Guillain-Barré syndrome. Neurocrit Care (2011) 0.77
Campylobacter jejuni HS:23 and Guillain-Barre syndrome, Bangladesh. Emerg Infect Dis (2009) 0.77
[Imminent respiratory insufficiency in children resulting from Guillain-Barré syndrome]. Ned Tijdschr Geneeskd (2011) 0.77
Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11. PLoS One (2010) 0.77
Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome. J Neuroimmunol (2005) 0.77
Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages. Infect Immun (2013) 0.77
Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study. J Neurol (2015) 0.76
Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Neurosci Lett (2003) 0.76
Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy. J Peripher Nerv Syst (2011) 0.76
Determination of pain and response to methylprednisolone in Guillain-Barré syndrome. J Neurol (2007) 0.75
Axonal variant of Guillain-Barre syndrome associated with campylobacter infection in Bangladesh. Neurology (2010) 0.75
Pain accompanies pure motor Guillain-Barré syndrome. J Peripher Nerv Syst (2008) 0.75
Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy. Nat Rev Neurol (2009) 0.75
Presence or absence of cytomegalovirus in cerebrospinal fluid from patients with Guillain-Barré syndrome? J Infect Dis (2006) 0.75
Dysfunction at the motor end-plate and axon membrane in Guillain-Barré syndrome: a single-fiber EMG study. Muscle Nerve (2003) 0.75
Diagnostic value of anti-GQ1b antibodies in a patient with relapsing dysarthria and ataxia. BMJ Case Rep (2009) 0.75
Author response. Neurology (2014) 0.75
Predicting the course of Guillain-Barré syndrome. Lancet Neurol (2006) 0.75
Immunotherapy for Guillain-Barré syndrome. Lancet Neurol (2004) 0.75
Guillain-Barré syndrome: background incidence rates in The Netherlands. J Peripher Nerv Syst (2011) 0.75
Historical sources of basilar artery occlusion. Neurology (2011) 0.75
Limb motor nerve dysfunction in Miller Fisher syndrome. J Peripher Nerv Syst (2013) 0.75
Individual patients who experienced both Guillain-Barré syndrome and CIDP. J Peripher Nerv Syst (2009) 0.75
Health-related quality of life in Guillain-Barré syndrome patients: a systematic review. J Peripher Nerv Syst (2014) 0.75
Selective depletion of neuropathy-related antibodies from human serum by monolithic affinity columns containing ganglioside mimics. J Med Chem (2011) 0.75
Transient hypertrichosis in a patient with Guillain-Barré syndrome. J Peripher Nerv Syst (2007) 0.75